A layperson summary should clearly share key information about a clinical trial in easy to understand language. But describing the results of a clinical trial in a way that everyone can understand is a difficult task and should always be developed and tested with patients and the public.
When developing the draft of a layperson summary, it is crucial to include external contributions to support both development, review and dissemination, ensuring the suitability of the document for patients, trial participants and the general public.
Patients in specific can contribute by providing perspectives and inject important considerations and insights into issues or terminologies that may differ from those of researchers and healthcare providers.
At Quotes, we are committed to strengthen your ability to communicate in a layperson language. And we are experienced in designing, testing and presenting your trial objectives, outcome and benefits, and improve your data transparency.
A lay person summary should clearly share key information about a clinical trial in easy to understand language. But describing the results of a clinical trial in a way that everyone can understand is a difficult task and should always be developed and tested with patients and the public.
When developing the draft of a layperson summary, it is crucial to include external contributions to support both development, review and dissemination, ensuring the suitability of the document for patients, trial participants and the general public.
Patients in specific can contribute by providing perspectives and inject important considerations and insights into issues or terminologies that may differ from those of researchers and healthcare providers.
At Quotes, we are committed to strengthen your ability to communicate in a layperson language. And we are experienced in designing, testing and presenting your trial objectives, outcome and benefits, and improve your data transparency.